IL166217A0 - Combination of drugs for the treatment of neoplasms - Google Patents
Combination of drugs for the treatment of neoplasmsInfo
- Publication number
- IL166217A0 IL166217A0 IL16621705A IL16621705A IL166217A0 IL 166217 A0 IL166217 A0 IL 166217A0 IL 16621705 A IL16621705 A IL 16621705A IL 16621705 A IL16621705 A IL 16621705A IL 166217 A0 IL166217 A0 IL 166217A0
- Authority
- IL
- Israel
- Prior art keywords
- neoplasms
- drugs
- treatment
- combination
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39523302P | 2002-07-11 | 2002-07-11 | |
| PCT/US2003/021803 WO2004006842A2 (en) | 2002-07-11 | 2003-07-11 | Combinations of drugs for the treatment of neoplasms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL166217A0 true IL166217A0 (en) | 2006-01-15 |
Family
ID=30115841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16621705A IL166217A0 (en) | 2002-07-11 | 2005-01-10 | Combination of drugs for the treatment of neoplasms |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20040116407A1 (xx) |
| EP (1) | EP1545544A2 (xx) |
| JP (1) | JP2005536509A (xx) |
| CN (1) | CN1681511A (xx) |
| AU (1) | AU2003256511A1 (xx) |
| BR (1) | BR0312597A (xx) |
| CA (1) | CA2492059A1 (xx) |
| HR (1) | HRP20050115A2 (xx) |
| IL (1) | IL166217A0 (xx) |
| IS (1) | IS7691A (xx) |
| MX (1) | MXPA05000485A (xx) |
| NO (1) | NO20050204L (xx) |
| RU (1) | RU2005103610A (xx) |
| WO (1) | WO2004006842A2 (xx) |
| ZA (1) | ZA200500618B (xx) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6569853B1 (en) * | 2000-11-06 | 2003-05-27 | Combinatorx, Incorporated | Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders |
| FR2842423B1 (fr) * | 2002-07-18 | 2005-07-08 | Centre Nat Rech Scient | Composes a activite anti-parasitaire et medicaments les renfermant |
| US7189740B2 (en) * | 2002-10-15 | 2007-03-13 | Celgene Corporation | Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes |
| WO2004079012A1 (en) * | 2003-03-03 | 2004-09-16 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Protein tyrosine phosphatase-prl-1 a a marker and therapeutic target for pancreatic cancer |
| US20050054708A1 (en) * | 2003-07-28 | 2005-03-10 | Nichols Matthew James | Combinations of drugs for the treatment of neoplasms |
| WO2005020913A2 (en) * | 2003-08-25 | 2005-03-10 | Combinatorx, Incorporated | Formulations, conjugates, and combinations of drugs for the treatment of neoplasms |
| CN1964714B (zh) * | 2003-08-29 | 2011-09-28 | Hdac默克研究有限责任公司 | 辛二酰苯胺异羟肟酸和吉西他滨在制备用于治疗癌症的药物中的用途 |
| CN1878556A (zh) * | 2003-09-18 | 2006-12-13 | 康宾纳特克斯公司 | 治疗肿瘤的联合药物 |
| US20050158320A1 (en) * | 2003-11-12 | 2005-07-21 | Nichols M. J. | Combinations for the treatment of proliferative diseases |
| US20050100508A1 (en) * | 2003-11-12 | 2005-05-12 | Nichols M. J. | Methods for identifying drug combinations for the treatment of proliferative diseases |
| EP1689705A4 (en) * | 2003-11-24 | 2007-08-29 | Univ North Carolina | DIAGNOSTIC ANTIPROTOZOENOMENTS WITH CONDENSED RING AND PRODRUGS THEREOF |
| WO2005070126A2 (en) * | 2004-01-08 | 2005-08-04 | The Regents Of The University Of Colorado | Methods and compositions for treating human diseases and wounds with ucp and fas inhibitors |
| BRPI0515774A (pt) * | 2004-12-15 | 2008-08-05 | Novartis Ag | combinações de agentes terapêuticos para o tratamento de cáncer |
| TW200719903A (en) * | 2005-04-19 | 2007-06-01 | Combinatorx Inc | Compositions for the treatment of neoplasms |
| JP2008539238A (ja) * | 2005-04-28 | 2008-11-13 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド | 治療用二機能性化合物 |
| AU2006242667A1 (en) * | 2005-05-02 | 2006-11-09 | The Regents Of The University Of Colorado | Systems and methods for treating human inflammatory and proliferative diseases, with a combination of compounds, or a bifunctional compound,that provides fatty acid metabolism and glycolysis inhibition |
| TW200716141A (en) * | 2005-05-05 | 2007-05-01 | Combinatorx Inc | Compositions and methods for treatment for neoplasms |
| AU2005339587B2 (en) * | 2005-11-16 | 2011-11-03 | Universidad Nacional Autonoma De Mexico | Use of transcriptome-modifying agents and chemotherapy or radiotherapy against cancer |
| US20080027008A1 (en) * | 2006-07-31 | 2008-01-31 | Jack Henkin | Antitumorigenic Drug Combination |
| EP2192904B1 (en) * | 2007-08-27 | 2016-08-17 | Auxagen, Inc. | METHODS FOR INHIBITING TGF-beta |
| US8394377B2 (en) * | 2008-02-21 | 2013-03-12 | The Regents Of The University Of Colorado | Methods for treating cancer using combination therapy |
| WO2010008554A2 (en) | 2008-07-14 | 2010-01-21 | The Regents Of The University Of Colorado | Methods and products for treating proliferative diseases |
| WO2010033507A1 (en) | 2008-09-16 | 2010-03-25 | St. Louis University | Method of enhancing tgf-beta signalling |
| EP2617414A3 (en) * | 2008-10-01 | 2013-11-06 | Novartis AG | Smoothened antagonism for the treatment of hedgehog pathway-related disorders |
| EP2424516A4 (en) * | 2009-05-01 | 2014-04-02 | Oncozyme Pharma Inc | PENTAMIDINE COMBINATIONS FOR THE TREATMENT OF CANCER |
| ITRM20090578A1 (it) * | 2009-11-10 | 2011-05-11 | Noi Per Voi Onlus | Nuove composizioni per il trattamento di leucemie chemioresistenti e/o di leucemie potenzialmente chemioresistenti. |
| US8809299B2 (en) * | 2012-03-28 | 2014-08-19 | Mcmaster University | Combination therapy for the treatment of cancer |
| CN105030785B (zh) * | 2015-06-30 | 2017-11-10 | 上海交通大学 | Promethazine在制备抗肝癌和/或结肠癌和/或肺癌产品中的应用 |
| EP4074315B1 (en) * | 2018-05-04 | 2023-08-09 | Korea Institute of Radiological & Medical Sciences | Radiation sensitivity enhancing composition containing aripiprazole as active ingredient |
| CN113264925A (zh) * | 2020-02-14 | 2021-08-17 | 上海美悦生物科技发展有限公司 | 一种杂环化合物及其制备方法和用途 |
| CN113304155B (zh) * | 2021-05-24 | 2023-03-24 | 四川大学华西医院 | 一种抗肿瘤的药物组合物及其制备方法和用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2645640A (en) * | 1953-07-14 | Phenthiazine derivatives | ||
| DE3827974A1 (de) * | 1988-08-18 | 1990-02-22 | Boehringer Mannheim Gmbh | Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen |
| US6569853B1 (en) * | 2000-11-06 | 2003-05-27 | Combinatorx, Incorporated | Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders |
-
2003
- 2003-07-11 WO PCT/US2003/021803 patent/WO2004006842A2/en active Application Filing
- 2003-07-11 BR BR0312597-1A patent/BR0312597A/pt not_active IP Right Cessation
- 2003-07-11 CA CA002492059A patent/CA2492059A1/en not_active Abandoned
- 2003-07-11 JP JP2004521730A patent/JP2005536509A/ja not_active Withdrawn
- 2003-07-11 RU RU2005103610/14A patent/RU2005103610A/ru not_active Application Discontinuation
- 2003-07-11 AU AU2003256511A patent/AU2003256511A1/en not_active Abandoned
- 2003-07-11 US US10/617,424 patent/US20040116407A1/en not_active Abandoned
- 2003-07-11 MX MXPA05000485A patent/MXPA05000485A/es not_active Application Discontinuation
- 2003-07-11 CN CNA038211513A patent/CN1681511A/zh active Pending
- 2003-07-11 EP EP03764557A patent/EP1545544A2/en not_active Withdrawn
-
2005
- 2005-01-10 IL IL16621705A patent/IL166217A0/xx unknown
- 2005-01-13 NO NO20050204A patent/NO20050204L/no not_active Application Discontinuation
- 2005-01-21 ZA ZA200500618A patent/ZA200500618B/xx unknown
- 2005-02-03 HR HR20050115A patent/HRP20050115A2/hr not_active Application Discontinuation
- 2005-02-09 IS IS7691A patent/IS7691A/is unknown
-
2006
- 2006-10-24 US US11/585,486 patent/US20070099905A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2005103610A (ru) | 2005-08-27 |
| IS7691A (is) | 2005-02-09 |
| EP1545544A2 (en) | 2005-06-29 |
| CN1681511A (zh) | 2005-10-12 |
| BR0312597A (pt) | 2005-05-10 |
| WO2004006842A3 (en) | 2004-05-27 |
| US20070099905A1 (en) | 2007-05-03 |
| US20040116407A1 (en) | 2004-06-17 |
| NO20050204L (no) | 2005-04-08 |
| ZA200500618B (en) | 2006-08-30 |
| AU2003256511A1 (en) | 2004-02-02 |
| HRP20050115A2 (en) | 2005-10-31 |
| WO2004006842A2 (en) | 2004-01-22 |
| MXPA05000485A (es) | 2005-04-19 |
| JP2005536509A (ja) | 2005-12-02 |
| CA2492059A1 (en) | 2004-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL166217A0 (en) | Combination of drugs for the treatment of neoplasms | |
| IL174232A0 (en) | Combinations of drugs for the treatment of neoplasms | |
| AU2003249244A1 (en) | Methods for the treatment of neoplasms | |
| PL375532A1 (en) | Benzimidazol-1-yl-thiophene compounds for the treatment of cancer | |
| HK1072443A1 (en) | Immunoconjugates for the treatment of tumours | |
| AU2003244650A8 (en) | Medicinal compounds | |
| GB0225540D0 (en) | Medicinal compounds | |
| GB0204719D0 (en) | Medicinal compounds | |
| GB0225535D0 (en) | Medicinal compounds | |
| GB0220730D0 (en) | Medicinal compounds | |
| GB0225030D0 (en) | Medicinal compounds | |
| HUS2200036I1 (hu) | Dihidroimidazolonok alkalmazása kutyák kezelésére | |
| EP1651211A4 (en) | COMBINATION OF MEDICAMENTS FOR THE TREATMENT OF NEOPLASMS | |
| AU2003251904A8 (en) | Combinations of drugs for the treatment of neoplasms | |
| AU2003251875A8 (en) | Combination therapy for the treatment of neoplasms | |
| GB0213869D0 (en) | The treatment of pain | |
| IL162818A0 (en) | Combination therapy for the treatment of bacterialinfections | |
| AU2003296545A8 (en) | Use of a trpm8-activating substance for the treatment of tumours | |
| PL1680405T3 (pl) | Pochodne bengamidu i ich zastosowanie do leczenia chorób nowotworowych | |
| EP1485077A4 (en) | DRUGS COMBINATION THERAPY | |
| SI1485057T1 (sl) | Derivati azaspiro spojin za zdravljenje bolecine | |
| GB0203173D0 (en) | The treatment of neurodegenerative disease | |
| SI1485352T1 (en) | Azaspiro compounds for the treatment of pain | |
| GB0315877D0 (en) | Compounds for the treatment of disease | |
| GB0224494D0 (en) | Medicinal compounds |